Department of Otolaryngology, Head and Neck Surgery, XiangYa School of Medicine, Central South University, Changsha, 410000, People's Republic of China.
Department of Otolaryngology, Head and Neck Surgery, Drum Tower Clinical Medical College, Nanjing Medical University, Nanjing, 210008, People's Republic of China.
Eur Arch Otorhinolaryngol. 2020 Feb;277(2):585-599. doi: 10.1007/s00405-019-05718-9. Epub 2019 Nov 11.
The purpose of this study was to systematically evaluate the risk factors of pharyngocutaneous fistula (PCF) after total laryngectomy.
We systematically searched Pubmed, Web of Science, Cochrane Library, and Embase databases and included the literature according to the inclusion and exclusion criteria.
A total of 52 studies with 8605 patients were included in the meta-analysis. The total incidence of PCF was 21% (1808/8605). Meta-analysis results indicated that age (OR = 1.29, 95% CI 1.06-1.58, P = 0.01), smoking (OR = 1.62, 95% CI 1.27-2.07, P < 0.01), COPD (chronic obstructive pulmonary disease) (OR = 1.62, 95% CI 1.19-2.22, P < 0.01), CAD (coronary atherosclerotic heart disease) (OR = 1.82, 95% CI 1.36-2.45, P < 0.01), T-stage (OR = 0.81, 95% CI 0.67-0.98, P = 0.03), previous radiotherapy (OR = 2.41, 95% CI 2.00-2.90, P < 0.01), preoperative albumin (OR = 2.95, 95% CI 1.47-5.91, P < 0.01), preoperative hemoglobin (OR = 1.97, 95% CI 1.28-3.03, P < 0.01), tumor site (OR = 0.28, 95% CI 0.22-0.36, P < 0.01), and treatment method (OR = 1.85, 95% CI 1.44-2.38, P < 0.01) were risk factors associated with PCF.
In our study, age, smoking, COPD, CAD, T-stage, previous radiotherapy, preoperative albumin, preoperative hemoglobin, tumor site, and treatment method were risk factors of PCF.
本研究旨在系统评估全喉切除术后咽瘘(PCF)的危险因素。
我们系统地检索了 Pubmed、Web of Science、Cochrane Library 和 Embase 数据库,并根据纳入和排除标准纳入了文献。
共有 52 项研究,8605 例患者纳入荟萃分析。PCF 的总发生率为 21%(1808/8605)。Meta 分析结果表明,年龄(OR=1.29,95%CI 1.06-1.58,P=0.01)、吸烟(OR=1.62,95%CI 1.27-2.07,P<0.01)、COPD(慢性阻塞性肺疾病)(OR=1.62,95%CI 1.19-2.22,P<0.01)、CAD(冠状动脉粥样硬化性心脏病)(OR=1.82,95%CI 1.36-2.45,P<0.01)、T 期(OR=0.81,95%CI 0.67-0.98,P=0.03)、术前白蛋白(OR=2.95,95%CI 1.47-5.91,P<0.01)、术前血红蛋白(OR=1.97,95%CI 1.28-3.03,P<0.01)、肿瘤部位(OR=0.28,95%CI 0.22-0.36,P<0.01)和治疗方法(OR=1.85,95%CI 1.44-2.38,P<0.01)是与 PCF 相关的危险因素。
在本研究中,年龄、吸烟、COPD、CAD、T 期、术前放疗、术前白蛋白、术前血红蛋白、肿瘤部位和治疗方法是 PCF 的危险因素。